Pratham Gokhale | Hindustan Times | Getty Images SINGAPORE – With mass vaccination campaigns against Covid-19 underway globally, there is an emerging gap between rich and poor nations in their abilities to secure enough shots to immunize their people.
Tedros Adhanom Ghebreyesus World Health Organization Director-General World Health Organization Director-General Tedros Adhanom Ghebreyesus said last week that drugmakers prioritized regulatory approval in rich countries where the profits are highest, rather than submitting full dossiers to expedite a global vaccine distribution initiative supported by the WHO.
India wants to burnish its credentials as a responsible global stakeholder while China would like to improve its reputation which got tarnished in the early stages of the Covid-19 pandemic.
Beijing is also giving priority access to its vaccines in places like Southeast Asia, which is of strategic importance to China.
Eurasia Group’s Bery said that one advantage India has is that the Serum Institute is one of the world’s largest vaccine manufacturers and that the country supplies more than 50% of the world’s vaccines.